Asthma Spacers Market Size, Share & Industry Analysis, By Type (Aerochamber, Optichamber, Volumatic, InspirEase), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Optical Stores, Online Pharmacies) And Regional Forecast, 2024-2032

Asthma spacers are devices in the form of tube that are attached to inhalers and help in providing drug doses for asthma patients. Spacer helps in delivering the accurate amount of dosage to the lungs. Also, the usage of spacers helps in avoiding side effects of the medicine. Therefore, asthma spacers are widely in demand for management of asthma. Increasing patient population worldwide is anticipated to rise the product sales in the forecast duration. Moreover, advancements pertaining to the devices such as high quality product and lower prices is also expected to favour the market growth.

The major factor driving the global asthma spacers market is the increasing prevalence of asthma worldwide. According to World Health Organization (WHO), people suffering from asthma as of November 2019 stand at 235 million. Thus, growing prevalence of the disorder owing to changing lifestyle, and genetic mutations is anticipated to facilitate market growth.

On the flip side, availability of alternative treatment solutions for asthma such as bronchial thermoplasty is likely to hinder the market growth during the forecast duration.

Market Segmentation:

By type, the global asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. Based on distribution channel, the market is classified as hospital pharmacies, retail pharmacies, optical stores, and online pharmacies.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The major companies in the global asthma spacers market report includes Koninklijke Philips N.V, GlaxoSmithKline Plc, Cipla Inc., Trudell Medical International, CONMED Corporation, AstraZeneca, Merck & Co., Inc, Allergan, Inc., Medical Developments International, and Others.

Key Insights

• Technological Advancements in the asthma spacers market


• Product Launch


• Prevalence of Asthma - For Key Regions/Countries


• COVID-19 Impact on the Global asthma spacers market


• Key Industry Developments – Mergers, Acquisitions, and Partnerships

Regional Analysis:

The global asthma spacers market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global market in 2019, owing to higher prevalence of asthma in the region and adoption of asthma spacers. Additionally, developments in the products is expected to boost the product demand. Awareness among the population about available products in the market is the major factor leading to increased sales and demand for spacers in the Asia Pacific countries. This along with growing mergers and acquisitions between industry players is likely to promote the sales of the products in countries like China, India, and other countries. However, Latin America and Middle East & Africa are likely to witness significant growth during the forecast duration owing to lower penetration of the products and awareness.

Segmentation

Asthma Spacers Industry Developments

• In April 2019, Cipla announced the launch of Niveoli. The product is India’s first beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults indicated against asthma and COPD.


• In February 2018, Teva pharmaceuticals announced the launch of QVAR RediHaler for treatment of asthma patients.